Long-Term Usage of Oral Glucocorticoids Leading to Adrenal Insufficiency: A Comprehensive Review of the Literature

Systemic glucocorticoid therapy is used worldwide by one to three percent of the general population and 0.5-1.8% on long-term oral glucocorticoid use. It is widely used in conditions such as inflammation, autoimmune diseases, and cancer to inhibit inflammatory responses. One of the possible undesira...

Descripción completa

Detalles Bibliográficos
Autores principales: Monge Chacón, Ana G, Wang, Chen, Waqar, Danish, Syeda, Saba Amreen, Kumar, Rohan, Meghana, D Ragasri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257969/
https://www.ncbi.nlm.nih.gov/pubmed/37309331
http://dx.doi.org/10.7759/cureus.38948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257969/
https://www.ncbi.nlm.nih.gov/pubmed/37309331
http://dx.doi.org/10.7759/cureus.38948

Ejemplares similares